These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16811099)

  • 1. Macrophage electrophoretic mobility test.
    Carr I
    J Clin Pathol; 1977 Jan; 30(1):91. PubMed ID: 16811099
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage response to concanavalin A: effect of surface crosslinking on the electrophoretic mobility distribution.
    Petty HR; Ware BR
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2278-82. PubMed ID: 287068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
    Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
    Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
    Metzner G; Jäger L
    Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
    Malkovský M; Bubeník J; Holán V; Hasek M
    Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
    Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
    Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.
    Mohamad SB; Nagasawa H; Sasaki H; Uto Y; Nakagawa Y; Kawashima K; Hori H
    Anticancer Res; 2003; 23(6a):4451-7. PubMed ID: 14666733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
    Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
    Günther J
    Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of DNA bending by Fos-Jun and phased A tracts by multifactorial phasing analysis.
    Kerppola TK
    Biochemistry; 1997 Sep; 36(36):10872-84. PubMed ID: 9283077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
    Rahi AH; Otiko G; Winder AF
    Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoretic mobility properties of murine hemopoietic cells in different stages of development.
    Bol S; van Vliet M; van Slingerland V
    Exp Hematol; 1981 Apr; 9(4):431-43. PubMed ID: 7238656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Newer aspects of the electrophoretic mobility test after stimulation of human lymphocytes with PPD].
    Gerstner L
    Onkologie; 1981 Feb; 4(1):42-7. PubMed ID: 7012734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to anticancer drugs permanently alters electrophoretic mobility of cancer cell lines.
    Kazan HH; Urfali-Mamatoglu C; Gündüz U
    Electrophoresis; 2017 Apr; 38(8):1201-1205. PubMed ID: 28158905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of monascus pigment derivatives on the electrophoretic mobility of bacteria, and the cell adsorption and antibacterial activities of pigments.
    Kim C; Jung H; Kim JH; Shin CS
    Colloids Surf B Biointerfaces; 2006 Feb; 47(2):153-9. PubMed ID: 16423514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.